Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				KTN32313R NCT00477282


2.		Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI, Other				MCC-13991 NCT00358319


3.		Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				KTN22208 NCT00097903


4.		Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				1 to 21				Other				H-20159 KTN10010, BMP1350, NCT00586560

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute